Sign In
Buy PFE
$26.04
+0.345 (+1.34%)
At Close: Jun 05, 2026
These 3 Stocks Just Spiked—Buy the Rally or Sell the News?
02:46pm, Monday, 14'th Oct 2024
Selling the news is a common trading strategy in which traders buy a stock in anticipation of expected news, then sell once the event occurs. It's a short-term strategy based on the psychology that th
Pfizer Secures FDA Approval for Hemophilia Drug Hympavzi
10:10am, Monday, 14'th Oct 2024
Following the FDA approval, PFE's Hympavzi becomes the first hemophilia medicine approved in the United States to be administered via a pre-filled, auto-injector pen.
Which Pharma Stock Is the Better Bargain Buy: Pfizer or Eli Lilly?
10:00am, Monday, 14'th Oct 2024
These two stocks will appeal to very different types of investors at the moment.
Prediction: These 2 High-Yield Dividend Stocks Will Outperform the S&P 500 Index in the Coming Decade
05:34am, Monday, 14'th Oct 2024
Buying these stocks gives you a great chance to beat the benchmark.
2 Unstoppable Growth Stocks to Buy Right Now for Less than $200
09:00am, Saturday, 12'th Oct 2024
These businesses are trading at discounts right now.
2 Incredibly Cheap Big Pharma Stocks to Buy Now
06:10am, Saturday, 12'th Oct 2024
There's doubtlessly some coming uncertainty for both, but the prices are right.
3 Reliable Dividend Stocks With Yields Above 5% That You Can Buy With Less Than $100 Right Now
05:26am, Saturday, 12'th Oct 2024
You don't need to be rich to put your money to work on Wall Street.
Bullish Underdogs and Big Winners: PYPL, PFE & AMZN
03:32pm, Friday, 11'th Oct 2024
Andrew Arons with Synergy Advisory Management remains bullish on the state of the markets, crediting A.I. stocks and the Fed's rate cut.
Pfizer wins FDA approval for hemophilia B drug that will be first once-weekly treatment
01:29pm, Friday, 11'th Oct 2024
The new drug would allow patients to produce the needed clotting protein for an extended period, reducing the need for constant intravenous infusions or injections, which are painful as well as inconv
US FDA approves Pfizer's drug for rare bleeding disorder
01:27pm, Friday, 11'th Oct 2024
The U.S. Food and Drug Administration approved Pfizer's once-a-week injection for the two main types of a rare bleeding disorder called hemophilia, the company said on Friday.
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved HYMPAVZI™ (marstacimab-hncq) for routine prophylaxis to prevent or re
An Activist Investor Just Bought $1 Billion Worth of Pfizer. Here's What It Means for the Stock
08:45am, Friday, 11'th Oct 2024
There may be changes coming to this company, if the activists get their way.
Why Pfizer Stock Tumbled by Nearly 3% on Thursday
05:51pm, Thursday, 10'th Oct 2024
The company's latest institutional shareholder has made some troubling allegations against it.
Pfizer battles activist fund Starboard, which has a $1 billion stake in company
03:51pm, Thursday, 10'th Oct 2024
CNBC Angelica Peebles joins 'Power Lunch' to report on Pfizer's activist battle.
Ex-Pfizer Execs Backed Its Leadership. An Activist Investor Says They Were 'Threatened'
01:40pm, Thursday, 10'th Oct 2024
Pfizer (PFE) shares lost ground Thursday after two former executives released a statement supporting the company's current management after activist investor Starboard Value this week took a $1 billio
